Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

被引：0
作者：
Matthias Totzeck
Nicolas Aide
Johann Bauersachs
Jan Bucerius
Panagiotis Georgoulias
Ken Herrmann
Fabien Hyafil
Jolanta Kunikowska
Mark Lubberink
Carmela Nappi
Tienush Rassaf
Antti Saraste
Roberto Sciagra
Riemer H. J. A. Slart
Hein Verberne
Christoph Rischpler
机构：
[1] University Hospital Essen,Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen
[2] University Duisburg-Essen,Nuclear Medicine Department
[3] University Hospital,Department of Nuclear Medicine
[4] Department of Cardiology and Angiology,Department of Nuclear Medicine, Faculty of Medicine
[5] Hannover Medical School,Clinic for Nuclear Medicine
[6] University Medicine Göttingen,Department of Nuclear Medicine
[7] Georg-August-University Göttingen,Nuclear Medicine Department
[8] University of Thessaly,Medical Physics
[9] University Hospital of Larissa,Department of Advanced Biomedical Sciences
[10] University Hospital Essen,Heart Center
[11] University of Duisburg-Essen,Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[12] DMU IMAGINA,Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging
[13] Georges-Pompidou European Hospital,Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC
[14] Assistance-Publique – Hôpitaux de Paris,undefined
[15] University of Paris,undefined
[16] Medical University of Warsaw,undefined
[17] Uppsala University Hospital,undefined
[18] University of Naples “Federico II”,undefined
[19] Turku University Hospital and University of Turku,undefined
[20] University of Florence,undefined
[21] University of Groningen,undefined
[22] University Medical Center Groningen,undefined
[23] Department of Biomedical Photonic Imaging,undefined
[24] Faculty of Science and Technology,undefined
[25] University of Amsterdam,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Nuclear medicine; Cancer therapy-related cardiotoxicity; Cardio-oncology; PET; SPECT; Chemotherapy; Radiotherapy; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：792 / 812
页数：20
相关论文
共 605 条
  • [1] Rassaf T(2020)Onco-cardiology: consensus paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology Clin Res Cardiol 109 1197-1222
  • [2] Totzeck M(2016)ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur Heart J 37 2768-801
  • [3] Backs J(2020)Oncocardiology: new challenges, new opportunities Herz 45 619-625
  • [4] Bokemeyer C(2021)Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors? Eur Heart J 42 1632-1635
  • [5] Hallek M(2022)Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies Eur Heart J 43 1928-1940
  • [6] Hilfiker-Kleiner D(2019)Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease Int J Cardiol 01 163-175
  • [7] Zamorano JL(2018)Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity J Thorac Dis 10 S4282-S4295
  • [8] Lancellotti P(2017)Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20 000 patients J Am Heart Assoc 6 e006278-e458
  • [9] Rodriguez Muñoz D(2018)Immune checkpoint inhibitors and cardiovascular toxicity Lancet Oncol 19 e447-651
  • [10] Aboyans V(2020)Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system Herz 45 645-1631
12345678910